Chemokine expression is upregulated in chondrocytes in diabetic fracture healing.

[1]  John M. Ashton,et al.  Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. , 2011, Blood.

[2]  M. Goldring,et al.  Inflammation in osteoarthritis , 2011, Current opinion in rheumatology.

[3]  S. Colucci,et al.  Osteoclastogenesis and arthritis , 2011, Clinical and Experimental Medicine.

[4]  G. Garlet,et al.  Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. , 2010, Bone.

[5]  Thomas A Einhorn,et al.  TNF-α Mediates Diabetes-Enhanced Chondrocyte Apoptosis During Fracture Healing and Stimulates Chondrocyte Apoptosis Through FOXO1 , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  Thomas A Einhorn,et al.  High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing. , 2009, The American journal of pathology.

[7]  D. Graves,et al.  Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. , 2009, Bone.

[8]  S. Davies,et al.  Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. , 2008, Osteoarthritis and cartilage.

[9]  Arata Nakajima,et al.  Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat. , 2008, Bone.

[10]  S. Colla,et al.  CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions. , 2008, Cancer research.

[11]  M. Thomassen,et al.  Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis , 2007, British journal of haematology.

[12]  D. Graves,et al.  Diminished Bone Formation During Diabetic Fracture Healing is Related to the Premature Resorption of Cartilage Associated With Increased Osteoclast Activity , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  G. Garlet,et al.  Chemokines in Oral Inflammatory Diseases: Apical Periodontitis and Periodontal Disease , 2007, Journal of dental research.

[14]  F. Canovas,et al.  Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes , 2007, Arthritis research & therapy.

[15]  K. Jepsen,et al.  Three-dimensional Reconstruction of Fracture Callus Morphogenesis , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  Gabriel S. Eichler,et al.  Analysis of fracture healing by large-scale transcriptional profile identified temporal relationships between metalloproteinase and ADAMTS mRNA expression. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[17]  C. Selinger,et al.  MCP-1-induced Human Osteoclast-like Cells Are Tartrate-resistant Acid Phosphatase, NFATc1, and Calcitonin Receptor-positive but Require Receptor Activator of NFκB Ligand for Bone Resorption* , 2006, Journal of Biological Chemistry.

[18]  T. Einhorn,et al.  Application of Histomorphometric Methods to the Study of Bone Repair , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  Frank Beier,et al.  Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy. , 2005, Molecular biology of the cell.

[20]  W. Maloney,et al.  Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. , 2005, Bone.

[21]  P. Tak,et al.  The role of chemokines in rheumatoid arthritis and osteoarthritis , 2005, Scandinavian journal of rheumatology.

[22]  G. Lisignoli,et al.  CXCL12 chemokine up‐regulates bone resorption and MMP‐9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients , 2004, Journal of cellular physiology.

[23]  D. Graves,et al.  Impaired Fracture Healing in the Absence of TNF‐α Signaling: The Role of TNF‐α in Endochondral Cartilage Resorption , 2003 .

[24]  L. Suva,et al.  Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. , 2003, Bone.

[25]  K. Moriyama,et al.  Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma , 2002 .

[26]  W. Sellers,et al.  A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. , 2002, Cancer cell.

[27]  K. Nagata,et al.  The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP-1, MIP-1α, MIP-1β, IP-10)-positive cells in human periapical granulomas , 2001 .

[28]  G. Roodman,et al.  Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. , 2001, Blood.

[29]  R. Borzì,et al.  Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis , 1999, FEBS letters.

[30]  G. Roodman Mechanisms of bone lesions in multiple myeloma and lymphoma , 1997, Cancer.

[31]  M. Burdick,et al.  Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. , 1995, The Journal of clinical investigation.

[32]  R. Loder,et al.  The influence of diabetes mellitus on the healing of closed fractures. , 1988, Clinical orthopaedics and related research.

[33]  A. Hirschman,et al.  Retardation of fracture healing in experimental diabetes. , 1968, The Journal of surgical research.

[34]  A. Koch,et al.  Chemokines and chemokine receptors in arthritis. , 2010, Frontiers in bioscience.

[35]  A. Mantovani,et al.  Chemokines and chemokine receptors: an overview. , 2009, Frontiers in bioscience.

[36]  R. Borzì,et al.  Down-modulation of chemokine receptor cartilage expression in inflammatory arthritis. , 2003, Rheumatology.

[37]  T A Einhorn,et al.  Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  K. Moriyama,et al.  Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma. , 2002, Blood.

[39]  K. Nagata,et al.  The presence of chemokine receptor (CCR5, CXCR3, CCR3)-positive cells and chemokine (MCP1, MIP-1alpha, MIP-1beta, IP-10)-positive cells in human periapical granulomas. , 2001, Cytokine.